Release 4 R5 Final QA

This page is part of the FHIR Specification (v4.0.1: R4 (v5.0.0-draft-final: Final QA Preview for R5 - Mixed Normative and STU see ballot notes ) in it's permanent home (it will always be available at this URL). ). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Codesystem-research-study-phase.json

Example OperationOutcome/allok (Turtle)

Biomedical Research and Regulation FHIR Infrastructure Work Group Maturity Level : N/A Standards Status : Informative Compartments : Not linked to any defined compartments
Raw

Raw Turtle (+ also see JSON Turtle/RDF Format Specification )

Definition for Code System ResearchStudyPhase An operation outcome that could be returned after a successful operation (no issues)

{ "resourceType" : "CodeSystem", "id" : "research-study-phase", "meta" : { "lastUpdated" : "2019-11-01T09:29:23.356+11:00" }, "text" : { "status" : "generated", "div" : "<div>!-- Snipped for Brevity --></div>" }, "extension" : [{ "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg", "valueCode" : "brr" }, { "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status", "valueCode" : "draft" }, { "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm", "valueInteger" : 1 }], "url" : "http://terminology.hl7.org/CodeSystem/research-study-phase", "identifier" : [{ "system" : "urn:ietf:rfc:3986", "value" : "urn:oid:2.16.840.1.113883.4.642.4.1247" }], "version" : "4.0.1", "name" : "ResearchStudyPhase", "title" : "ResearchStudyPhase", "status" : "draft", "experimental" : false, "date" : "2019-11-01T09:29:23+11:00", "publisher" : "HL7 (FHIR Project)", "contact" : [{ "telecom" : [{ "system" : "url", "value" : "http://hl7.org/fhir" }, { "system" : "email", "value" : "fhir@lists.hl7.org" }] }], "description" : "Codes for the stage in the progression of a therapy from initial experimental use in humans in clinical trials to post-market evaluation.", "caseSensitive" : true, "valueSet" : "http://hl7.org/fhir/ValueSet/research-study-phase", "content" : "complete", "concept" : [{ "code" : "n-a", "display" : "N/A", "definition" : "Trials without phases (for example, studies of devices or behavioral interventions)." }, { "code" : "early-phase-1", "display" : "Early Phase 1", "definition" : "Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0." }, { "code" : "phase-1", "display" : "Phase 1", "definition" : "Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients." }, { "code" : "phase-1-phase-2", "display" : "Phase 1/Phase 2", "definition" : "Trials that are a combination of phases 1 and 2." }, { "code" : "phase-2", "display" : "Phase 2", "definition" : "Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks." }, { "code" : "phase-2-phase-3", "display" : "Phase 2/Phase 3", "definition" : "Trials that are a combination of phases 2 and 3." }, { "code" : "phase-3", "display" : "Phase 3", "definition" : "Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug." }, { "code" : "phase-4", "display" : "Phase 4", "definition" : "Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use." }] }
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

[a fhir:OperationOutcome ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "allok"] ; # 
  fhir:text [
     fhir:status [ fhir:v "generated" ] ;
     fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <p>All OK</p>\n    </div>"
  ] ; # 
  fhir:issue ( [
     fhir:severity [ fhir:v "information" ] ;
     fhir:code [ fhir:v "informational" ] ;
     fhir:details [
       fhir:text [ fhir:v "All OK" ]
     ]
  ] )] . # 

# -------------------------------------------------------------------------------------



Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.